• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Step Edits Associated with IV Iron Therapies

Opinion
Video

Panelists discuss how increasing insurance step edit requirements for high-dose IV iron formulations have created barriers to optimal patient care, requiring providers to implement strategic prior authorization processes and develop documentation protocols to demonstrate medical necessity while advocating for appropriate patient access to these medications.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
4 experts are featured in this series.
1 expert is featured in this series.
Anna Mueller, MD, Mount Sinai
Marc Humbert, MD, PhD
John Ostrominski, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.